House Republicans to probe FDA's delayed decision on decongestants

Oral decongestants with phenylephrine in the U.S. generated almost $1.8 billion in sales last year, FDA data shows.

Related Keywords

United States ,American ,Americans ,Lisa Mcclain ,Vicks Dayquil ,Financial Services ,Johnson ,Drug Administration ,House Subcommittee On Health Care ,House Republicans ,House Subcommittee ,Health Care ,Robert Califf ,Chairwoman Lisa Mcclain ,